Alexey S. Kononikhin

Blood-based proteomics for schizophrenia: candidate biomarkers for risk assessment and precision psychiatry

Schizophrenia (SCZ) is a severe mental disorder where diagnosis remains subjective, and treatment efficacy is limited by high heterogeneity, particularly for negative and cognitive symptoms. There is an urgent need for objective molecular biomarkers, especially for early diagnosis and for identifying individuals at cli...